We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?
Read MoreHide Full Article
Key Takeaways
Altria's on! reached 8.7% U.S. oral tobacco share, up 0.7 points from the prior year.
The brand's 26.5% shipment jump to 52.1M cans drove segment profit growth.
Helix drives on!'s growth through event marketing and rising brand awareness.
Altria Group, Inc.’s ((MO - Free Report) ) investment in the smoke-free future is anchored by its on! nicotine pouches, which were the primary driver of growth in the oral tobacco products segment for the second quarter of 2025. The brand’s strong performance pushed its retail share of the total U.S. oral tobacco category to 8.7%, reflecting a 0.7 share point increase compared with the prior year. Within the rapidly expanding nicotine pouch category specifically, on! is dominant, now representing more than half of the category after growing 10 share points year over year.
The impressive growth was underlined by a 26.5% increase in reported shipment volume in the second quarter, reaching 52.1 million cans. This increase drove the majority of the segment’s substantial profit growth for the quarter.
The key question remains how Altria can maintain this momentum in an increasingly competitive environment. The company’s strategy, executed by its subsidiary Helix, focuses on aggressive brand-building to differentiate on! from rivals and build emotional connections with adult consumers.
This involves high-impact, in-person activations at events such as NASCAR races and music festivals, reaching more than 170,000 adult tobacco consumers in the first half of the year. Combined with 190 million digital impressions in the second quarter, these initiatives lifted on!’s brand awareness by 7 percentage points in the first half of 2025. Altria is focused on driving trial, building long-term equity and increasing profitability to cement on!'s competitive advantage in the fast-growing smoke-free market.
How PM & TPB Stack Up Against Altria
Philip Morris International Inc. ((PM - Free Report) ) continues to accelerate its transformation, with smoke-free products driving 41% of total net revenues and more than 42% of gross profit in the second quarter of 2025. Smoke-free business of Philip Morris, spanning IQOS, ZYN and VEEV, delivered 11.8% shipment growth and a 23.3% jump in gross profit. With availability across 97 markets, Philip Morris is leveraging scale, innovation and category breadth to reinforce its leadership in the global smoke-free transition.
Turning Point Brands, Inc. ((TPB - Free Report) ) is rapidly emerging as a serious contender in the modern oral nicotine space, fueled by breakout performance from its FRE and ALP pouch brands. In the second quarter of 2025, Turning Point Brands’ Modern Oral sales surged nearly eightfold year over year to $30.1 million, accounting for 26% of total revenues. Turning Point Brands raised its full-year Modern Oral sales outlook to $100-$110 million, indicating continued confidence in the category’s long-term growth potential.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have gained 15.4% in the past three months against the industry’s decline of 4.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 12.05X, down from the industry’s average of 14.27X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.6%, respectively.
Image: Bigstock
MO's on! Hits 8.7% Oral Tobacco Share: Can It Fend Off Competitors?
Key Takeaways
Altria Group, Inc.’s ((MO - Free Report) ) investment in the smoke-free future is anchored by its on! nicotine pouches, which were the primary driver of growth in the oral tobacco products segment for the second quarter of 2025. The brand’s strong performance pushed its retail share of the total U.S. oral tobacco category to 8.7%, reflecting a 0.7 share point increase compared with the prior year. Within the rapidly expanding nicotine pouch category specifically, on! is dominant, now representing more than half of the category after growing 10 share points year over year.
The impressive growth was underlined by a 26.5% increase in reported shipment volume in the second quarter, reaching 52.1 million cans. This increase drove the majority of the segment’s substantial profit growth for the quarter.
The key question remains how Altria can maintain this momentum in an increasingly competitive environment. The company’s strategy, executed by its subsidiary Helix, focuses on aggressive brand-building to differentiate on! from rivals and build emotional connections with adult consumers.
This involves high-impact, in-person activations at events such as NASCAR races and music festivals, reaching more than 170,000 adult tobacco consumers in the first half of the year. Combined with 190 million digital impressions in the second quarter, these initiatives lifted on!’s brand awareness by 7 percentage points in the first half of 2025. Altria is focused on driving trial, building long-term equity and increasing profitability to cement on!'s competitive advantage in the fast-growing smoke-free market.
How PM & TPB Stack Up Against Altria
Philip Morris International Inc. ((PM - Free Report) ) continues to accelerate its transformation, with smoke-free products driving 41% of total net revenues and more than 42% of gross profit in the second quarter of 2025. Smoke-free business of Philip Morris, spanning IQOS, ZYN and VEEV, delivered 11.8% shipment growth and a 23.3% jump in gross profit. With availability across 97 markets, Philip Morris is leveraging scale, innovation and category breadth to reinforce its leadership in the global smoke-free transition.
Turning Point Brands, Inc. ((TPB - Free Report) ) is rapidly emerging as a serious contender in the modern oral nicotine space, fueled by breakout performance from its FRE and ALP pouch brands. In the second quarter of 2025, Turning Point Brands’ Modern Oral sales surged nearly eightfold year over year to $30.1 million, accounting for 26% of total revenues. Turning Point Brands raised its full-year Modern Oral sales outlook to $100-$110 million, indicating continued confidence in the category’s long-term growth potential.
Altria’s Price Performance, Valuation & Estimates
Shares of Altria have gained 15.4% in the past three months against the industry’s decline of 4.3%.
Image Source: Zacks Investment Research
From a valuation standpoint, MO trades at a forward price-to-earnings ratio of 12.05X, down from the industry’s average of 14.27X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for MO’s 2025 and 2026 earnings implies year-over-year growth of 6.1% and 2.6%, respectively.
Image Source: Zacks Investment Research
Altria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.